Solara Active Pharma Sciences Limited has informed the Exchange about the revised Intimation of Schedule of Analyst / Institutional Investor call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, to be held on Friday, February 06, 2026 at 3:30 P.M. to discuss the Company's unaudited financial results for the quarter ended December 31, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has issued a revised intimation about an analyst and institutional investor call scheduled for Friday, February 6, 2026, at 3:30 PM. The call will discuss the company's unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). The filing has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The word 'revised' indicates an update to a previously communicated schedule for the same call.
This is a routine administrative update about the timing of an upcoming earnings call — no direct impact on shareholders or stock price is expected. Investors should watch for the actual Q3 FY26 results, which will likely be disclosed around or before this call.